Immune Thrombocytopenia Market Set for Significant Growth by 2036, Driven by Emerging Targeted Therapies and Rising Diagnosis Rates | DelveInsight

AI Briefing

• – Immune Thrombocytopenia market expected to grow steadily across 7MM from 2026-2036 due to emerging therapies and rising diagnosis rates.
• – Increasing disease awareness and improving diagnostic capabilities driving market growth.
• – Emerging therapies like Ianalumab, Mezagitamab, and PF-06835375 to play key role in market expansion.